Innovation Crossroads: Tech, Business, and Global Impact

Tired of confusing plans and long hold times? One firm is expanding a free 'white glove' service nationwide, aiming to disrupt how we buy connectivity.

Rebranding from nanotech to lithium, Summit completes a key engineering step for its modular extraction plants, poised to tackle the global lithium shortage.

Caliway Biopharma advances its fat-loss drug, promising objective, MRI-verified results in a market hungry for safer, more reliable aesthetic options.

A Singaporean group just bought a century-old Milanese tailor. Can 3D scanning and global ambition coexist with a legacy built on the motto 'Never bend'?

Pioneers of IVF technology are launching a clinical skincare program, aiming to merge cellular science with holistic patient support in fertility clinics.

The tech giants expand their partnership to create an "agentic enterprise," leveraging AI in Slack to transform operations and customer support.

New Guanlan Encoding promises to halve video storage needs, a huge win for security budgets. But can the tech giant outrun its controversial reputation?

Binance now lets you bet on SpaceX’s IPO before it happens. Is this the democratization of finance or a high-risk gamble for the average investor?

One William Street expands its capital deal with Affirm to $4 billion, a major vote of confidence in the BNPL giant's credit model and technology.

The Council on Foreign Relations begins a multiyear effort to forge a new American foreign policy, aiming to bridge partisan divides and connect with the public.

As AI promises flawless communication, one CEO argues that authentic presence, not digital perfection, is the key to leading through uncertainty.

How a unique public-private partnership is transforming Cleveland from one of America's worst-connected cities into a national blueprint for digital equity.

Three ZenaTech AI drone platforms have entered the final cybersecurity phase for Blue UAS certification, a critical step to accessing the U.S. defense market.

SponsorCX's latest funding round signals a major shift in the $100B+ sponsorship industry, as AI platforms replace spreadsheets and demand real ROI.

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

Hong Kong's PolyU is leading a global charge, uniting scientists and masters to prove the medical power of Tai Chi and Qigong.

EdTech firm Nerd Apply hires admissions reformer Erwin Hesse, signaling a bold move to use its massive data trove to legislate and reform college access.

Westaim posted a $33.4M Q1 loss, but strong early sales from its new annuity product suggest a long-term strategic transformation is taking root.

Soaring costs and long waits at home are driving thousands of Europeans to Albania for dental implants, where clinics offer top-tier care for less.

S&S Activewear's new AI platform, 17 years in the making, aims to eliminate out-of-stocks and reshape how apparel is distributed across North America.